251 related articles for article (PubMed ID: 17487490)
1. Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival.
Griffiths RW; Elkord E; Gilham DE; Ramani V; Clarke N; Stern PL; Hawkins RE
Cancer Immunol Immunother; 2007 Nov; 56(11):1743-53. PubMed ID: 17487490
[TBL] [Abstract][Full Text] [Related]
2. Frequency and gene expression profile of regulatory T cells in renal cell carcinoma.
Jeron A; Pfoertner S; Bruder D; Geffers R; Hammerer P; Hofmann R; Buer J; Schrader AJ
Tumour Biol; 2009; 30(3):160-70. PubMed ID: 19609102
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
[TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.
Siddiqui SA; Frigola X; Bonne-Annee S; Mercader M; Kuntz SM; Krambeck AE; Sengupta S; Dong H; Cheville JC; Lohse CM; Krco CJ; Webster WS; Leibovich BC; Blute ML; Knutson KL; Kwon ED
Clin Cancer Res; 2007 Apr; 13(7):2075-81. PubMed ID: 17404089
[TBL] [Abstract][Full Text] [Related]
5. Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma.
Cesana GC; DeRaffele G; Cohen S; Moroziewicz D; Mitcham J; Stoutenburg J; Cheung K; Hesdorffer C; Kim-Schulze S; Kaufman HL
J Clin Oncol; 2006 Mar; 24(7):1169-77. PubMed ID: 16505437
[TBL] [Abstract][Full Text] [Related]
6. Effect of Peripheral Blood CD4 + CD25 + Regulatory T Cell on Postoperative Immunotherapy for Patients with Renal Carcinoma.
Zhang CH; Huang Y
Asian Pac J Cancer Prev; 2016; 17(4):2027-30. PubMed ID: 27221890
[TBL] [Abstract][Full Text] [Related]
7. Down syndrome, autoimmunity and T regulatory cells.
Pellegrini FP; Marinoni M; Frangione V; Tedeschi A; Gandini V; Ciglia F; Mortara L; Accolla RS; Nespoli L
Clin Exp Immunol; 2012 Sep; 169(3):238-43. PubMed ID: 22861363
[TBL] [Abstract][Full Text] [Related]
8. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
[TBL] [Abstract][Full Text] [Related]
9. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
10. Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients.
Xufré C; Costa M; Roura-Mir C; Codina-Busqueta E; Usero L; Pizarro E; Obiols G; Jaraquemada D; Martí M
Int Immunol; 2013 Oct; 25(10):563-74. PubMed ID: 23929911
[TBL] [Abstract][Full Text] [Related]
11. [Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+ CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma].
Liu CF; Guo Z; Si TG; Xing WG; Liu F; Xing JZ
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(13):902-5. PubMed ID: 20646510
[TBL] [Abstract][Full Text] [Related]
12. [Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR(+)CD25⁻ cell subset in patients with systemic lupus erythematosus].
Alunno A; Nocentini G; Bistoni O; Bianchini R; Bartoloni Bocci E; Riccardi C; Gerli R
Reumatismo; 2010; 62(3):195-201. PubMed ID: 21052566
[TBL] [Abstract][Full Text] [Related]
13. Expansion of regulatory GITR+CD25 low/-CD4+ T cells in systemic lupus erythematosus patients.
Nocentini G; Alunno A; Petrillo MG; Bistoni O; Bartoloni E; Caterbi S; Ronchetti S; Migliorati G; Riccardi C; Gerli R
Arthritis Res Ther; 2014 Sep; 16(5):444. PubMed ID: 25256257
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
[TBL] [Abstract][Full Text] [Related]
15. Lack of anti-tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinoma.
Vyth-Dreese FA; Sein J; van de Kasteele W; Dellemijn TA; van den Bogaard C; Nooijen WJ; de Gast GC; Haanen JB; Bex A
Clin Exp Immunol; 2010 Dec; 162(3):447-59. PubMed ID: 20942806
[TBL] [Abstract][Full Text] [Related]
16. Reduced frequency and functional defects of CD4
Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
[TBL] [Abstract][Full Text] [Related]
17. Involvement of CD4+CD25+ regulatory T cells in the pathogenesis of polycythaemia vera.
Zhao WB; Li Y; Liu X; Zhang LY; Wang X
Chin Med J (Engl); 2008 Sep; 121(18):1781-6. PubMed ID: 19080357
[TBL] [Abstract][Full Text] [Related]
18. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
Kuhn A; Beissert S; Krammer PH
Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
[TBL] [Abstract][Full Text] [Related]
19. Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profile.
De Somer L; Fevery S; Bullens DM; Rutgeerts O; Lenaerts C; Mathieu C; Boon L; Kasran A; Waer M; Billiau AD
Immunol Lett; 2010 Sep; 133(1):49-53. PubMed ID: 20600326
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 expression and infiltration by CD4
Lee HJ; Shin DH; Lee YJ; Lee SJ; Hwang CS; Kim A; Park WY; Lee JH; Choi KU; Kim JY; Lee CH; Sol MY; Park SW
Histopathology; 2020 Apr; 76(5):714-721. PubMed ID: 31841221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
